Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > MedCap Advisors Names Edward Ahn Managing Director and Chief Science Officer

Abstract:
MedCap Advisors, the mergers & acquisition and strategic consulting firm specializing in medical technology, today announced it has appointed Edward Ahn, Ph. D., as Managing Director and Chief Science Officer. Dr. Ahn is a leading expert in the development and commercialization of biomaterials nanotechnology, with over 10 years of industrial and academic experience.

MedCap Advisors Names Edward Ahn Managing Director and Chief Science Officer

Cambridge, MA | Posted on September 8th, 2012

"We are extremely fortunate to have a professional of Edward's caliber join our firm," said Mr. Christopher Velis, CEO of MedCap Advisors. "His expertise is perfectly in tune with our mission to improve health and medical technology, as we stay focused on the intersection at which physicians and patients meet. Ed will be a significant contributor to our team and to our clients."

Dr. Ahn most recently served as Vice President of Biologics Product Development for Pioneer® Surgical Technology, Inc. and its newly formed biologics division. He successfully developed and launched novel synthetic bone grafts, allograft-based tissue products and structural calcium phosphate nanotechnology in interbody spinal fusion.

In 2001, Dr. Ahn won the Grand Prize in the MIT $50k Business Plan Competition and subsequently used his thesis to found Angstrom Medica, a company focused on commercializing nanotechnology in orthopedics. Here he achieved the first nanomedical device approved by the FDA in 2005; the company was subsequently acquired by Pioneer® Surgical Technology, Inc.

Dr. Ahn earned his B.S. in Chemical Engineering from Stanford University and M.S. in Chemical Engineering Practice and Ph.D. in Chemical Engineering from MIT. Presently he is a senior lecturer at Harvard University's School of Engineering and Applied Science, and is the Vice-Chairman of the MIT Enterprise Forum of Cambridge. He is also a member of the Scientific Advisory Board of the Center of Innovation for Nanobiotechnology (COIN) and a principal of First Founders, Ltd., a not-for-profit corporation dedicated to building young business ventures emerging from academic and other institutional research.

This announcement also follows on the news of MedCap's move to larger space in Harvard Square in Cambridge.

####

About MedCap Advisors
MedCap Advisors, LLC provides sophisticated strategic business and M&A consulting services exclusively to the medical technology and healthcare sectors. With more than 20 years of expertise in emerging medical devices, biotechnologies, and biologics, the firm's advisers are authorities in the full spectrum of strategic, scientific, and financial strategies that drive the medical marketplace. For more information, please visit www.medcapadvisors.com.

Contacts:
Ebben Zall Group
Michelle Juralewicz
781-449-3244

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Leti Presents Advances in Propagation Modeling and Antenna Design for mmWave Spectrum: Paper Is One of 15 that Leti Presented at European Conference on Antennas and Propagation March 19-24 March 23rd, 2017

Rice U. refines filters for greener natural gas: New study defines best materials for carbon capture, methane selectivity March 23rd, 2017

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Caught on camera -- chemical reactions 'filmed' at the single-molecule level March 22nd, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

TriboTEX Uses Nanotechnology to Improve the Efficiency of Old Vehicles March 13th, 2017

Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017

Consulting

Lucintel identifies and prioritizes opportunities for alumina trihydrate (ATH) fillers in the global composites industry August 3rd, 2016

Haydale Wins Major Research Grants September 26th, 2015

Silicon Valley-Based Foresight Valuation Launches STR-IP™, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014

California Nanotechnologies Appoints Dr. Enrique Lavernia to the Board August 6th, 2014

Nanomedicine

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Nanoparticle paves the way for new triple negative breast cancer drug March 20th, 2017

Block copolymer micellization as a protection strategy for DNA origami March 17th, 2017

Nanocages for gold particles: what is happening inside? March 16th, 2017

Announcements

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Rice U. refines filters for greener natural gas: New study defines best materials for carbon capture, methane selectivity March 23rd, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Appointments/Promotions/New hires/Resignations/Deaths

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project